Quarterly assessments

Antiepileptics Monitor patients for dizziness, fatigue, nausea, and paresthesias. Assess changes in weight at quarterly intervals. 

Weight should be monitored monthly for 3 months, then quarterly. Body mass index, waist circumference, blood pressure, fasting plasma glucose, and fasting lipid profile should be monitored at the end of 3 months, then annually. The use of patient self-assessments are encouraged. 

Over the last quarter century the dissolution test has emerged as a most powerful and valuable tool to guide formulation development, monitor the manufacturing process, assess product quality, and in some cases to predict in vivo performance of solid oral dosage forms. Under certain conditions, the dissolution test can be used as a surrogate measure for bioequivalence (BE) and to provide biowaivers, assuring BE of the product. Dissolution test has turned out to be a... 

Jones, E. (2003). Beyond supply and demand Assessing the Ph.D. job market. Occupational Outlook Quarterly (Winter 2002/2003), 22-23. 

HEAST. 1990. Health Effects Assessment Summary Tables. 3rd quarter FY-1990. Washington, DC U.S. Environmental Protection Agency. 

Copper porphyrin is one of the best-characterized of the metalloporphyrins, and its electron spin resonance (ESR) spectrum has been known for a quarter of a century.(17) More recently, electron nuclear double resonance (ENDOR) investigations have provided the complete hyperfine tensors for the metal, the nitrogens and the pyrrole protons.(18) We have used this detailed knowledge earlier(, ) to assess the quality of scattered-wave calculations. 

Monitoring Assess neutrophil counts prior to initiating anakinra treatment, and while receiving anakinra, monthly for 3 months, and thereafter quarterly for a period up to 1 year. 

Patient reported outcomes (disability index, patient global assessment), physician assessments (tender/painful/swollen joints, physician s global assessment), objective measures (ESR, CRP) neutrophil counts baseline, q3mo, then quarterly qyr... 

The belief in some quarters that patients have proprietary rights over their samples and any information generated therefrom, and that even anonymised data should not be divulged without permission may cause difficulties even for routine services with no overt research brief, putting interlaboratory audits and external quality assessment schemes at risk. 

WHO (2001) Biomarkers in Risk Assessment Validity and Validation, EHC222, WHO Head Quarter, Geneva, Switzerland. 

Beginning in 1993, the USEPA initiated compliance monitoring of finished water for atrazine, simazine, and several other chemicals. Surface water supplies were monitored quarterly, and groundwater supplies were monitored once or twice annually. The purpose was to assess annual running mean concentrations of atrazine and simazine for each CWS for compliance with their respective MCLs (Table 29.1). 

---